Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Deferred Taxes (2022 - 2026)

Centessa Pharmaceuticals has reported Deferred Taxes over the past 4 years, most recently at $233000.0 for Q4 2025.

  • Quarterly Deferred Taxes fell 41.46% to $233000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Dec 2025, down 5.43% year-over-year, with the annual reading at $2.5 million for FY2025, 5.43% down from the prior year.
  • Deferred Taxes was $233000.0 for Q4 2025 at Centessa Pharmaceuticals, down from $255000.0 in the prior quarter.
  • Over five years, Deferred Taxes peaked at $1.3 million in Q3 2024 and troughed at -$23.5 million in Q2 2023.
  • The 4-year median for Deferred Taxes is $255000.0 (2025), against an average of -$1.9 million.
  • Year-over-year, Deferred Taxes plummeted 2040.74% in 2023 and then surged 367.11% in 2024.
  • A 4-year view of Deferred Taxes shows it stood at -$2.8 million in 2022, then skyrocketed by 94.63% to -$149000.0 in 2023, then surged by 367.11% to $398000.0 in 2024, then plummeted by 41.46% to $233000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Deferred Taxes are $233000.0 (Q4 2025), $255000.0 (Q3 2025), and $1.0 million (Q2 2025).